Computer-aided quantification of retinal neovascularization

被引:0
作者
A. Stahl
K. M. Connor
P. Sapieha
K. L. Willett
N. M. Krah
R. J. Dennison
J. Chen
K. I. Guerin
L. E. H. Smith
机构
[1] Harvard Medical School,Department of Ophthalmology
[2] Children’s Hospital Boston,undefined
[3] University Eye Hospital Freiburg,undefined
来源
Angiogenesis | 2009年 / 12卷
关键词
Oxygen-induced retinopathy; OIR; Retina; Neovascularization; Quantification; SWIFT_NV;
D O I
暂无
中图分类号
学科分类号
摘要
Rodent models of retinal angiogenesis play a pivotal role in angiogenesis research. These models are a window to developmental angiogenesis, to pathological retinopathy, and are also in vivo tools for anti-angiogenic drug screening in cancer and ophthalmic research. The mouse model of oxygen-induced retinopathy (OIR) has emerged as one of the leading in vivo models for these purposes. Many of the animal studies that laid the foundation for the recent breakthrough of anti-angiogenic treatments into clinical practice were performed in the OIR model. However, readouts from the OIR model have been time-consuming and can vary depending on user experience. Here, we present a computer-aided quantification method that is characterized by (i) significantly improved efficiency, (ii) high correlation with the established hand-measurement protocols, and (iii) high intra- and inter-individual reproducibility of results. This method greatly facilitates quantification of retinal angiogenesis while at the same time increasing lab-to-lab reproducibility of one of the most widely used in vivo models in angiogenesis research.
引用
收藏
页码:297 / 301
页数:4
相关论文
共 17 条
  • [1] Rosenfeld PJ(2006)Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419-1431
  • [2] Ranieri G(2006)Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic Curr Med Chem 13 1845-1857
  • [3] Smith LE(1994)Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 101-111
  • [4] Pierce EA(1995)Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 92 905-909
  • [5] Smith LE(1999)Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor Nat Med 5 1390-1395
  • [6] Aiello LP(1995)Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins Proc Natl Acad Sci USA 92 10457-10461
  • [7] Bainbridge JW(2002)Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1 Gene Ther 9 320-326
  • [8] Ozaki H(2000)Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization Am J Pathol 156 697-707
  • [9] Rota R(2004)Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer J Gene Med 6 992-1002
  • [10] Sone H(1999)Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy Life Sci 65 2573-2580